Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
When planning a moderately hypofractionationed treatment for prostate cancer, do you recommend using a bladder volume dose constraint?
For example V70<10cc? Or do you stick with % of organ volume dose constraints?
Answer from: Radiation Oncologist at Community Practice
We aim for 70 Gy < 10 and 35 Gy < 40 - 50 and try to avoid hot spot in bladder trigone region.
Comments
Radiation Oncologist at CCare
I noticed 70Gy <10cc and the lower V40 constrai...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
We do treat all with hypofractionation.
6198
6199
Sign In
or
Register
to read more
10419
Related Questions
What is the rationale for the recent change in the NCCN criteria for very high risk prostate cancer?
How can you manage a patient with bilateral PCNs who requires Pluvicto administration?
What are your top takeaways in GU Cancers from ASCO 2025?
Does non-urothelial histology impact your approach to chemoradiotherapy for muscle-invasive bladder cancer?
What time frame, number of PSAs, and calculator do you use for calculating PSA doubling times?
How does the presence of indeterminate lymphadenopathy on PSMA PET scan alter your management of unfavorable intermediate-risk prostate cancer?
What would your approach be in a man currently on treatment for high-risk prostate cancer with ADT who does not have castrate levels of testosterone?
Would you continue serial PSMA PET scans after 2 negative scans for patients with a persistently rising PSA post-RT?
Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?
Do you recommend neoadjuvant 177Lu-PNT2002 followed by MDT per the LUNAR trial as your preferred treatment approach for oligorecurrent prostate cancer, as opposed to MDT and PSMA-radioligand therapy used as temporally separate treatments?
I noticed 70Gy <10cc and the lower V40 constrai...
We do treat all with hypofractionation.